Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Ravdin

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Bulletin Du Cancer|December 1, 1995
A computer based program to assist in adjuvant therapy decisions for individual breast cancer patientsP M Ravdin
Seminars in Oncology|February 1, 1996
A computer program to assist in making breast cancer adjuvant therapy decisionsP M Ravdin
Hematology/Oncology Clinics of North America|February 1, 1994
A practical view of prognostic factors for staging, adjuvant treatment planning, and as baseline studies for possible future therapyP M Ravdin
Anti-Cancer Drugs|August 1, 1996
Treatment of patients resistant to anthracycline therapyP M Ravdin
Seminars in Oncology|April 1, 1995
Review of docetaxel (Taxotere), a highly active new agent for the treatment of metastatic breast cancerP M Ravdin, V Valero
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
Decision-making in early breast cancer: guidelines and decision toolsM Baum, P M Ravdin
Cancer Letters|March 15, 1994
A technique for using neural network analysis to perform survival analysis of censored dataM De Laurentiis, P M Ravdin
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1979
Inhibition of neuronal acetylcholine sensitivity by alpha-toxins from Bungarus multicinctus venomP M Ravdin, D K Berg
Gene|June 14, 1995
The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers--a reviewP M Ravdin, G C Chamness
Breast Cancer Research and Treatment|January 1, 1994
Survival analysis of censored data: neural network analysis detection of complex interactions between variablesM De Laurentiis, P M Ravdin
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|December 1, 1995
A computer based program to assist in adjuvant therapy decisions for individual breast cancer patientsP M Ravdin
Seminars in Oncology|February 1, 1996
A computer program to assist in making breast cancer adjuvant therapy decisionsP M Ravdin
Hematology/Oncology Clinics of North America|February 1, 1994
A practical view of prognostic factors for staging, adjuvant treatment planning, and as baseline studies for possible future therapyP M Ravdin
Anti-Cancer Drugs|August 1, 1996
Treatment of patients resistant to anthracycline therapyP M Ravdin
Seminars in Oncology|April 1, 1995
Review of docetaxel (Taxotere), a highly active new agent for the treatment of metastatic breast cancerP M Ravdin, V Valero
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
Decision-making in early breast cancer: guidelines and decision toolsM Baum, P M Ravdin
Cancer Letters|March 15, 1994
A technique for using neural network analysis to perform survival analysis of censored dataM De Laurentiis, P M Ravdin
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1979
Inhibition of neuronal acetylcholine sensitivity by alpha-toxins from Bungarus multicinctus venomP M Ravdin, D K Berg
Gene|June 14, 1995
The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers--a reviewP M Ravdin, G C Chamness
Breast Cancer Research and Treatment|January 1, 1994
Survival analysis of censored data: neural network analysis detection of complex interactions between variablesM De Laurentiis, P M Ravdin
Pageof 6